Diarrhoea is one of the more common gastrointestinal side effects, though typically less prevalent than nausea
1,2 As scientists continue to investigate established and new therapeutic applications, GLP-1 receptor (GLP-1R) agonists such as semaglutide, dulaglutide, and tirzepatide have become increasingly relevant tools in preclinical research
(2015) investigated this mechanism using a working memory task (N-back), applying two tDCS sessions with opposite polarities to the dorsolateral prefrontal cortex (DLPFC) separated by a time interval (Carvalho et al., 2015)
While promising, it has not yet received FDA approval and is not available for clinical use outside of research settings
Another study, this one conducted in weight lifters, has shown that 2 grams of L-carnitine L-tartrate (LCLT), taken once daily, can increase oxygen delivery to cells, shedding light on yet another mechanism by which carnitine may improve cellular metabolism